The Board of Directors of Daito Pharmaceutical Co.,Ltd. has authorized a buyback plan on April 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,549 JPY | +1.88% | +0.95% | +33.81% |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.81% | 250M | |
+21.91% | 43.95B | |
+21.54% | 22.49B | |
+14.56% | 14.71B | |
+13.13% | 13.77B | |
+46.96% | 12.3B | |
-8.66% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.